X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6236) 6236
Publication (519) 519
Newsletter (178) 178
Book Review (72) 72
Book Chapter (32) 32
Magazine Article (12) 12
Conference Proceeding (10) 10
Book / eBook (9) 9
Newspaper Article (4) 4
Data Set (2) 2
Dissertation (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3910) 3910
male (3321) 3321
index medicus (2814) 2814
female (2576) 2576
animals (2186) 2186
middle aged (1813) 1813
natriuretic peptides (1754) 1754
natriuretic peptide, brain - blood (1733) 1733
aged (1644) 1644
heart failure (1635) 1635
brain natriuretic peptide (1575) 1575
cardiac & cardiovascular systems (1555) 1555
rats (1297) 1297
heart failure - drug therapy (953) 953
adult (948) 948
mortality (890) 890
biomarkers - blood (861) 861
peptide fragments - blood (773) 773
research (764) 764
treatment outcome (732) 732
hypertension (678) 678
natriuretic peptide (673) 673
heart (660) 660
pharmacology & pharmacy (659) 659
heart-failure (657) 657
heart failure - physiopathology (640) 640
risk factors (619) 619
peptides (613) 613
prognosis (607) 607
care and treatment (580) 580
physiology (567) 567
atrial natriuretic factor - pharmacology (559) 559
heart failure - blood (551) 551
blood pressure - drug effects (547) 547
echocardiography (532) 532
brain (502) 502
biomarkers (501) 501
blood pressure (491) 491
peripheral vascular disease (488) 488
prospective studies (484) 484
aged, 80 and over (482) 482
diagnosis (465) 465
analysis (464) 464
time factors (459) 459
cardiology (452) 452
natriuretic peptide, brain (443) 443
atrial natriuretic factor - blood (442) 442
physiological aspects (432) 432
health aspects (431) 431
heart diseases (424) 424
cardiovascular disease (423) 423
dose-response relationship, drug (419) 419
atrial natriuretic peptide (418) 418
natriuretic peptide, brain - metabolism (417) 417
atrial-natriuretic-peptide (391) 391
medicine (390) 390
rats, sprague-dawley (384) 384
mice (380) 380
cardiac patients (376) 376
heart attacks (373) 373
medicine, research & experimental (373) 373
drug therapy (370) 370
rodents (369) 369
cells, cultured (366) 366
endocrinology & metabolism (366) 366
disease (363) 363
cardiovascular diseases (351) 351
expression (350) 350
research article (347) 347
abridged index medicus (346) 346
dysfunction (342) 342
atrial natriuretic factor - metabolism (337) 337
patients (335) 335
heart failure - diagnosis (332) 332
hypertrophy (322) 322
studies (319) 319
congestive-heart-failure (318) 318
rats, wistar (316) 316
myocardium - metabolism (315) 315
risk (312) 312
follow-up studies (307) 307
myocardial-infarction (303) 303
medicine, general & internal (302) 302
double-blind method (296) 296
plasma (294) 294
hemodynamics - drug effects (289) 289
therapy (289) 289
left-ventricular dysfunction (286) 286
bnp (280) 280
natriuretic peptide, brain - therapeutic use (279) 279
biochemistry & molecular biology (277) 277
neurosciences (273) 273
multidisciplinary sciences (272) 272
cardiovascular (270) 270
medical research (257) 257
acute myocardial-infarction (254) 254
natriuretic peptide, brain - pharmacology (254) 254
predictive value of tests (253) 253
inflammation (248) 248
c-reactive protein (247) 247
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6300) 6300
Chinese (62) 62
Russian (22) 22
Japanese (18) 18
French (17) 17
German (12) 12
Spanish (11) 11
Polish (6) 6
Czech (4) 4
Italian (4) 4
Portuguese (3) 3
Hungarian (2) 2
Norwegian (2) 2
Romanian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 50, Issue 17, pp. 1657 - 1665
Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency Jorge Eduardo Toblli, Alejandra... 
Cardiovascular | Internal Medicine | HEMOGLOBIN | MORTALITY | INDEPENDENT PREDICTOR | CARDIAC & CARDIOVASCULAR SYSTEMS | SUBCUTANEOUS ERYTHROPOIETIN | IV IRON | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | EXERCISE TOLERANCE | CHRONIC KIDNEY-DISEASE | DEFICIENCY | Anemia, Iron-Deficiency - drug therapy | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Natriuretic Peptide, Brain - metabolism | Heart Failure - physiopathology | Ferric Compounds - administration & dosage | Male | Renal Insufficiency, Chronic - complications | Anemia, Iron-Deficiency - blood | Renal Insufficiency, Chronic - metabolism | C-Reactive Protein - metabolism | Aged, 80 and over | Female | C-Reactive Protein - drug effects | Biomarkers - metabolism | Heart Failure - complications | Peptide Fragments - metabolism | Double-Blind Method | Anemia, Iron-Deficiency - etiology | Treatment Outcome | Heart Failure - metabolism | Hospitalization | Renal Insufficiency, Chronic - physiopathology | Hematinics - administration & dosage | Pilot Projects | Glucaric Acid | Natriuretic Peptide, Brain - drug effects | Exercise Tolerance | Peptide Fragments - drug effects | Quality of Life | Aged | Infusions, Intravenous | Heart failure | Kidney failure | C-reactive protein | Erythropoietin | Anemia | Cardiac patients | Hemoglobin | Natriuretic peptides | Heart | Chronic kidney failure | Body mass index | Drug therapy | Mortality
Journal Article
JAMA, ISSN 0098-7484, 01/2009, Volume 301, Issue 4, pp. 383 - 392
Journal Article
Journal Article
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 03/2016, Volume 310, Issue 6, pp. H667 - H680
Mitochondrial dysfunction has been implicated as a cause of energy deprivation in heart failure (HF). Herein, we tested individual and combined effects of two... 
heart failure | nitric oxide | angiotensin II | mitochondria | oxidative stress | Mitochondria, Heart - metabolism | Gene Expression - drug effects | DNA, Mitochondrial - drug effects | Mitochondria, Heart - drug effects | Calcium-Calmodulin-Dependent Protein Kinase Type 2 - drug effects | Electron Transport Complex I - metabolism | Sarcoplasmic Reticulum Calcium-Transporting ATPases - drug effects | Cardiomegaly | Myocardium - metabolism | Natriuretic Peptide, C-Type - drug effects | Heart Failure - etiology | Pyruvate Dehydrogenase Complex - drug effects | NG-Nitroarginine Methyl Ester - pharmacology | Pyruvate Dehydrogenase Complex - metabolism | Vasoconstrictor Agents - pharmacology | Angiotensin II - pharmacology | Natriuretic Peptide, Brain - genetics | Protein Precursors - genetics | DNA, Mitochondrial - metabolism | Enzyme Inhibitors - pharmacology | Myocardium - pathology | Reverse Transcriptase Polymerase Chain Reaction | Electron Transport Complex I - drug effects | Hydrogen Peroxide - metabolism | Calcium-Calmodulin-Dependent Protein Kinase Type 2 - genetics | Animals | Protein Precursors - drug effects | Electron Transport Complex II - metabolism | Natriuretic Peptide, Brain - drug effects | Heart - drug effects | Natriuretic Peptide, C-Type - genetics | Mice | Oxidative Stress - drug effects | Electron Transport Complex II - drug effects | Nitric Oxide - metabolism | Sarcoplasmic Reticulum Calcium-Transporting ATPases - genetics
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 10/2017, Volume 313, Issue 4, pp. H690 - H699
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 164, Issue 6, pp. 902 - 909.e2
Journal Article
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2015, Volume 192, Issue 9, pp. 1102 - 1110
Journal Article
Journal Article
Journal Article